Cisplatin clearance

Author: zjgh

August undefined, 2024

WebNational Center for Biotechnology Information WebCisplatin dose adjustment in patients with renal impairment must be improved. Estimating GFR with the aMDRD formula and adding an intermediary level of dose reduction for …

Renal Clearance - an overview ScienceDirect Topics

WebJun 19, 2024 · This work allows us to appreciate the evolution of cisplatin clearance during the first weeks of age. Interestingly, our patient had a cisplatin CL on cycle 1 which was markedly lower than the CL observed in another previously treated 2-week-old baby (2.9 mL/min/kg compared to 10.6 mL/min/kg [ 6 ]), highlighting the differences in ... WebSep 21, 2016 · In 25 patients assessable for both courses, the use of a fixed dose of cisplatin resulted in reduced exposure to unbound platinum in patients at the upper extremes of BSA (P = .003) and higher exposures in patients at the lower extremes (P = .009), as compared with exposures following the BSA-adjusted dose.Although clearance … danfoss icon handleiding

Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin …

WebFeb 16, 2016 · All patients were treated with high-dose cisplatin CCRT. The main outcome parameters were nephrotoxicity (defined as creatinine clearance grade 2 or more) and cumulative doses of cisplatin and radiation. Results: 133 patients (64%) completed all pre-planned courses of cisplatin. Nephrotoxicity was the main reason to discontinue the … WebFeb 16, 2024 · This drug should be administered by slow IV infusion. Do not give by rapid IV infusion. Pretreatment hydration with 1 to 2 liters of fluid infused for 8 to 12 hours … WebCisplatin for injection has been administered at 75 mg/m. 2 . to 100 mg/m. intravenously per cycle once every 3 to 4 weeks on Day 1. Other doses and combination regimens have … danfoss ip55 box

Weekly high-dose cisplatin is a feasible treatment option: analysis on ...

History of Changes for Study: NCT02365766 - clinicaltrials.gov

WebMar 9, 2024 · Currently, societies of nephrology recommend dose reductions in cisplatin for patients with renal insufficiency of creatinine clearance (CrCl) between 30 and 60 mL/min. 10-12 Among their recommendations, unified protocol based on Kintzel's indication is especially popular. 10, 11, 13 Kintzel et al reported an indicator of cisplatin dose ... WebOct 1, 2024 · Cisplatin is a potent chemotherapeutic used for the treatment of many types of cancer. However, its dose-limiting side effect is nephrotoxicity leading to acute kidney injury (AKI). ... In addition, mice and humans differ in their rate of cisplatin clearance. The peak plasma concentration of cisplatin is 2.4–20 times greater in mice than in ... birmingham ics nhsWebPretreatment with cisplatin has been reported to increase MTX toxicity, possibly by decreasing renal clearance (40). AKI prolongs extrarenal toxicity (myelosuppression and … danfoss icon master controller 24v manual

"" - Cisplatin clearance

Cisplatin clearance

Developing better mouse models to study cisplatin-induced …

WebJan 7, 2024 · Kidney function was monitored by weekly eGFR and 51 Cr-EDTA clearance measurements; the first measurements were performed prior to receiving any treatment and the comparative measurements were performed after the third treatment with cisplatin. The cisplatin treatment would be discontinued in case of 51 Cr-EDTA clearance decreasing … WebBACKGROUND: Cisplatin-based chemotherapy is the first-line (1L) treatment for eligible patients with locally advanced/metastatic urothelial carcinoma (mUC). However, many patients with mUC are ineligible for cisplatin-based therapy due to age- or dis ... These considerations included renal impairment (creatinine clearance <60 mL/min ...

Did you know?

WebAug 31, 2024 · The recommended dose of ALIMTA when administered with cisplatin for initial treatment of locally advanced or metastatic non-squamous NSCLC in patients with a creatinine clearance (calculated by Cockcroft-Gault equation) of 45 mL/min or greater is 500 mg/m 2 as an intravenous infusion over 10 minutes administered prior to cisplatin on … WebJul 1, 1982 · The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid The mechanism of renal …

WebJan 11, 2024 · According to current clinical trial eligibility criteria, patients with muscle-invasive bladder cancer (MIBC) and baseline renal clearance of 40–60 ml/min can … WebCreatinine clearance ( CrCl) is an estimate of Glomerular Filtration Rate ( GFR ); however, CrCl is slightly higher than true GFR because creatinine is secreted by the proximal tubule (in addition to being filtered by the glomerulus). The additional proximal tubule secretion falsely elevates the CrCl estimate of GFR. 12

WebALIMTA in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. ... creatinine clearance of ≥ 45 ml/min required no dose adjustments other than those recommended for all patients. There are insufficient data on the use of pemetrexed in patients with ... WebJan 7, 2024 · As cytotoxic cisplatin levels within a tumor depend heavily on the competition between drug diffusion and clearance, spatial variations in the cisplatin diffusion coefficient and clearance rate ...

WebBackground A strategy for preventing cisplatin nephrotoxicity due to enhanced oxidative stress and inflammatory response is highly desirable. Thioredoxin-1 (Trx), an endogenous redox-active protein,

WebCisplatin is a clinically advanced and highly effective anticancer drug that is used for the treatment of various solid tumors, such as lung cancer, stomach cancer, and ovarian cancer [ 1 ].... danfoss it toolsWebApr 15, 2003 · It is noteworthy that cisplatin dose (in the range 70–80 mg m −2) was not associated with nephrotoxicity and that baseline creatinine clearance did not predict for nephrotoxicity (defined as ... danfoss l and k motorWebFor research use only. Cisplatin (NSC 119875, Cisplatinum, cis-diamminedichloroplatinum II, CDDP, cis DDP, DDP) is an inorganic platinum complex, which is able to inhibit DNA synthesis by conforming DNA … birmingham ics ceoWebSep 15, 2024 · Cisplatin is a prescription medicine used to treat the symptoms of cancer in the testicles (Metastatic Testicular Tumors), bladder (Advanced Bladder Cancer) and … danfoss industriesWebClearance of cisplatin, etoposide, and ifosfamide depends on kidney function and dosages should be adjusted in patients with renal impairment. However, there is still limited data on the adherence of physicians to dosing recommendations for these drugs in cancer patients with renal impairment. danfoss jackson mi phone numberWebThe intraperitoneal injection of cisplatin increased kidney weight, serum cystatin-c, and serum creatinine, at the same time, decreased body weight, urinary volume, urine creatinine, creatinine clearance, and renal antioxidant activity, all of which were significant. birmingham icon galleryWebwith three cycles of cisplatin 70 mg/qm2 on day 1 and methotrexate 40 mg/qm2 on days 8 and 15 of a 21-day cycle (CM) or three cycles of methotrexate 30 mg/qm2 on days 1, 15, and 22, vinblastine 3 mg/qm2 on days 2, 15, and 22, epirubicin 45 mg/qm2 on day 2, and cisplatin 70 mg/qm2 on day 2 of a 28-day cycle (M-VEC). Results danfoss link cc nsu